Ken Aldape
National Cancer Institute(US)Center for Cancer Research(US)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Cancer Genomics and Diagnostics, Brain Metastases and Treatment, Cancer Cells and Metastasis, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → The transcriptional network for mesenchymal transformation of brain tumours(2009)1,282 cited
- → The integrated landscape of driver genomic alterations in glioblastoma(2013)554 cited
- → Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme(2005)402 cited
- → MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance(2009)381 cited
- → Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma(2020)235 cited
- → Temozolomide-Mediated Radiation Enhancement in Glioblastoma: A Report on Underlying Mechanisms(2006)224 cited
- → Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)(2009)160 cited
- → Phase II Trial of Tipifarnib in Patients With Recurrent Malignant Glioma Either Receiving or Not Receiving Enzyme-Inducing Antiepileptic Drugs: A North American Brain Tumor Consortium Study(2006)154 cited
- → Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: Case study(2007)126 cited
- → Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma(2008)115 cited